Pharma company ranking by product delivery in developing countries 2024

This statistic depicts the pharmaceutical company ranking based on product donations in developing countries as of 2024, according to the Access to Medicine Index. In that year, the company with the highest score in the product delivery category in these countries was GSK, scoring 3.77 points. Product delivery includes, among others, patent transparency and sharing of intellectual property assets.

Pharmaceutical company ranking based on product delivery in developing countries as of 2024

Characteristic	Indicator score from 1 (lowest) to 5 (highest)
GSK plc	3.77
Novartis AG	3.74
Pfizer Inc.	3.58
AstraZeneca plc	3.51
Sanofi	3.49
Johnson & Johnson	3.37
Novo Nordisk A/S	3.35
Boehringer-Ingelheim GmbH	3.34
Merck KGaA	3.25
Bayer AG	3.21
Takeda Pharamceutical Co.	3.17
Roche Holding Ltd.	3.03
Eisai Co. Ltd.	2.78
Bristol-Myers Squibb Co.	2.72
Gilead Sciences Inc.	2.2
Astellas Pharma Inc.	2
Merck & Co. Inc.	1.97
Daiichi Sankyo Co. Ltd.	1.85
AbbVie Inc.	1.75
Eli Lilly & Co.	1.72

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2024

More information

Region

Worldwide

Survey time period

As of November 2024

Supplementary notes

The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.

Open this statistic in...

Spanish

Citation formats